Health

  • US to assign 3,000 from US military to fight Ebola

    The Obama administration is ramping up its response to West Africa's Ebola crisis, preparing to assign 3,000 U.S. President Barack Obama planned to announce the stepped up effort Tuesday during a visit to the federal Centers for Disease Control and Prevention in Atlanta amid alarm that the outbreak…

    Associated Press42 mins ago
  • Stagnant floodwater raising health risk in Kashmir

    Health workers were scrambling Tuesday to manage a mounting health crisis nearly two weeks after massive flooding engulfed much of Kashmir, where they are treating cases of diarrhea, skin allergies and fungus as they hope the stagnant waters do not create conditions for more serious disease…

    Associated Press
  • Northwest Bio drug gets first slot under UK early access scheme

    An experimental Northwest Biotherapeutics  drug for inoperable tumors is the first medicine to have been selected for fast-track designation under a new early access scheme in Britain. Doctors will be able to prescribe the new drug once the Medicines and Healthcare Products Regulatory Agency, the…

    Reuters
  • Medical Labs Make Test Results Easier for Patients to Understand

    As more patients gain direct access to lab reports and test results, health care providers are offering new tools to help them navigate the maze of numbers and use the data to better manage their own care. Individual patients now can see their results on a wide variety of medical tests including…

    The Wall Street Journal
  • Depression and Sisyphus

    Depression and SisyphusI'm very lucky and blessed that I have an abundance of friends who don't suffer chemical depression. Like anybody, they occasionally suffer from situational depression -- the circumstances they find themselves in when the universe

    Huffington Post
  • QLT Unveils Positive Retreatment Study Data

    QLT Unveils Positive Retreatment Study Data QLT Inc. (QLTI) announced encouraging final data on its pipeline candidate QLT091001 from an international, multi-center phase Ib retreatment extension study (n=27). The study evaluated the candidate in patients

    Zacks
  • For Dialysis Patients, a Less Clinical Experience

    In a bid to win business and encourage patients to keep up with their treatments, some dialysis centers are upgrading their décor and offering free amenities from aromatherapy to tea service. The goal is to dispel the clinical air of typical dialysis treatment. "We don't want to look like a…

    The Wall Street Journal
  • Play

    UNWANTED SOLUTION: WHY NO ONE'S BUYING OBESITY DRUGS

    Anti-obesity drugs are hard to sell in the U.S., despite a population where more than one in three adults is obese.

    TouchVision
  • Ebola Pledges Lagged in Crisis's Early Months

    Months after the Ebola virus started spreading in West Africa, the world's largest donors and organizations are pledging hundreds of millions of dollars to combat it. Documented pledges or donations totaled $326.7 million as of Monday, according to data from the Financial Tracking Service, managed…

    The Wall Street Journal
  • Radiologists Push for Medical Reports Patients Can Understand

    Imagine reading a medical report about yourself that is clear, concise and respectful of your feelings. As more patients gain direct access to their electronic health records, some radiologists are leading a push to demystify the medical mumbo jumbo those patients will find there. Radiologists, who…

    The Wall Street Journal
  • Black Lung Disease Rates Skyrocket To Highest Levels Since 1970s

    Black Lung Disease Rates Skyrocket To Highest Levels Since 1970sThe proportion of coal miners who suffer from an advanced form of black lung disease has skyrocketed in central Appalachia in recent years, according to experts with the National Institute

    Huffington Post
  • Novartis Presents Positive Data on Lucentis and Jetrea

    Novartis Presents Positive Data on Lucentis and Jetrea Novartis (NVS) presented encouraging data on Lucentis and Jetrea at the EURETINA congress in London. Novartis' Lucentis is approved for various ocular indications – wet age-related macular degeneration

    Zacks
  • Medical Calculators Use Big Data to Help Patients Make Choices

    Doctors and patients are crunching big data together using a simple calculator that helps the patients make informed medical decisions. Physicians have long relied on a range of resources—including medical literature, their own research and experience, and pure gut feelings—to give patients an idea…

    The Wall Street Journal
  • The Meds Pharmacists Take When They Get Sick

    This non-drowsy formula contains two misery-fighting ingredients: ibuprofen and pseudoephedrine. “Reducing prostaglandin levels reduces inflammation and pain sensation,” Michelle Arkin, an associate professor of pharmaceutical chemistry at UC San Francfisco, told Yahoo Health in an email.  “It will…

    Yahoo Health
  • ASU QB Taylor Kelly Out For A Month With Broken Foot

    Arizona State quarterback Taylor Kelly is expected to miss at least a month after breaking a bone in his left foot during Saturday night's game against the Colorado Buffaloes. According to an article on ArizonaSports.com, ASU QB Taylor Kelly broke a bone in his left foot during Saturday night's win…

    SB Nation
  • [video] Avanir up on Alzheimer's trial

    [video] Avanir up on Alzheimer's trialAvanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO

    CNBC
  • RG3 says he doesn’t have a fracture, likely won’t need surgery

    Robert Griffin III got relatively good news after an MRI today. Griffin, who left Sunday’s game in Washington with an ankle injury, said today that an MRI revealed he does not have a fracture and does not think he will need surgery.

    ProFootball Talk on NBC Sports
  • $1,000-a-pill hep C treatment to be cheaper abroad

    Hepatitis C patients in developing countries could soon gain access to a cheaper, generic version of a drug that sells for $1,000 a pill in the USA. Gilead Sciences (GILD), which makes the drug, announced Monday that it has signed a licensing agreement with seven companies in India to make generic…

    USA TODAY
  • 1 Tip To Lose Belly Fat

    It's Hollywood's Hottest Diet And Gets Rid Of Stubborn Fat Areas Like Nothing Else.

    AdChoicesagoodcooksSponsored
  • NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote

    NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote NPS Pharmaceuticals (NPSP) received encouraging news when the Endocrinologic and Metabolic Drugs Advisory Committee (:EMDAC) of the FDA recommended the approval of the company’s hormone replacement

    Zacks